FDA Drug Application (202157) for LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE by HETERO LABS UNIT III

Back to FDA Applications sponsored by HETERO LABS UNIT III

Application Number202157
Product Number001
FormTABLET; ORAL
Dosage150MG; 200MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Active IngredientLAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient NEVIRAPINE17
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by HETERO LABS UNIT III